GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

We share the goal of advancing the development of BNT327/PM8002 for future combination therapies in the fight against cancer,” said Xiaolin Liu ... will be available shortly after the event’s ...

Champion is now the only doctor left on P.E.I. with experience treating blood diseases and cancers. "I'm anticipating fully ...

A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...

Reducing the risk of metastatic relapse in patients with resectable soft tissue sarcomas is crucial for improving outcomes, because metastasis is the primary cause of mortality in this population.

Oscar B. Lahoud, MD, cochair of a recent Institute for Value-Based Medicine ® event hosted with NYU Langone Health, knows the ...

Objective: Recent studies have shown a potential link between the gut microbiome and colorectal cancer (CRC). A wide array of ...

Syndax Pharmaceuticals advances Revumenib for relapsed AML with FDA decision pending. See why SNDX stock is a key player in ...

A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...

Research shows mitochondria form distinct subpopulations under nutrient stress, revealing survival mechanisms in cancer cells ...

Background Peritoneal metastasis is the most common metastasis pattern of gastric cancer. Patients with gastric cancer ...

New study introduces a simple blood test to detect early lung damage in cancer patients receiving novel therapy with antibody ...